Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
Journal of Cancer Research and Clinical Oncology|April 4, 2008
IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC)Petra Richter, Kerstin Junker, Marcus Franz, et al.Histochemistry and Cell Biology|July 30, 2005
Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC)Petra Richter, Frank D Böhmer, Winfried Hindermann, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 8, 2010
EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332Petra Richter, Claudia Umbreit, Marcus Franz, et al.Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.Journal of Cancer Research and Clinical Oncology|March 5, 2004
Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipientsPeter Schleier, Peter Hyckel, Alexander Berndt, et al.Neoplasia (New York, N.Y.)|November 3, 2009
The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinomaMarta Cesca, Roberta Frapolli, Alexander Berndt, et al.Cardiovascular Diagnosis and Therapy|May 21, 2026
Certain role of extra-domain A containing fibronectin in the development of pulmonary hypertension in the sugen/hypoxia mouse modelClara Gutte, Katja Grün, Laura Tempel, et al.Oncotarget|November 27, 2018
MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasionVolker Ast, Theresa Kordaß, Marcus Oswald, et al.Histochemistry and Cell Biology|March 19, 2010
A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodiesAlexander Berndt, Robert Köllner, Petra Richter, et al.Blood|February 28, 2002
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrixBarbara Carnemolla, Laura Borsi, Enrica Balza, et al.Pageof 10